Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype.
Ontology highlight
ABSTRACT: The CMS4 mesenchymal subtype of colorectal cancer (CRC) is associated with poor prognosis and resistance to treatment. The cellular prion protein PrPC is overexpressed in CMS4 tumors and controls the expression of a panel of CMS4-specific genes in CRC cell lines. Here, we sought to investigate PrPC downstream pathways that may underlie its role in CMS4 CRC. By combining gene set enrichment analyses and gain and loss of function approaches in CRC cell lines, we identify the integrin-linked kinase ILK as a proximal effector of PrPC that mediates its control on the CMS4 phenotype. We further leveraged three independent large CRC cohorts to assess correlations in gene expression pattern with patient outcomes and found that ILK is overexpressed in CMS4 mesenchym
SUBMITTER: Ghazi A
PROVIDER: S-EPMC8244775 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA